Aromatic Heterocyclic Compounds Targeting 5-HT6 Receptor
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Alzheimer's disease and related central nervous system disorders lack effective compounds that specifically target the 5-HT6 receptor, which is implicated in cognitive enhancement and other neurological conditions, and there is a need for more potent therapeutic agents.
Innovation Solution
Development of novel aromatic heterocyclic compounds with affinity for the 5-HT6 receptor, specifically designed to act as antagonists, which can be used in pharmaceutical compositions to treat Alzheimer's disease and other related disorders.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If current treatments for Alzheimer's disease are used, then existing therapeutic options are available, but they lack effective compounds that specifically target the 5-HT6 receptor
Solution Approach 1:
The patent segments the broad class of serotonin receptor ligands into a specific subclass designed to selectively target the 5-HT6 receptor. By focusing on compounds with particular structural features (aromatic heterocyclic cores with specific substituent patterns), the invention isolates and optimizes activity at the 5-HT6 receptor subtype, resolving the contradiction between general effectiveness and receptor-specific targeting.
Solution Approach 2:
The patent applies local quality by introducing specific functional groups and substituent patterns at particular positions on the heterocyclic core structure. These localized structural modifications (such as specific R1, R2, R3, R4 substituents on the core heterocycle) are designed to enhance binding affinity and selectivity for the 5-HT6 receptor, thereby achieving both effectiveness and specificity simultaneously.
2Reliability
If novel aromatic heterocyclic compounds are developed to target 5-HT6 receptor, then cognitive enhancement and therapeutic effects are achieved, but the complexity of drug development increases
Solution Approach 1:
The patent employs a universal heterocyclic core structure that can accommodate multiple different substituent patterns while maintaining 5-HT6 receptor affinity. This modular approach allows a single core scaffold to serve multiple therapeutic purposes and be optimized for different pharmacological properties, reducing the need to develop entirely new complex structures for each therapeutic indication.
Solution Approach 2:
The patent systematically varies parameters such as substituent types, positions, and configurations on the heterocyclic core to optimize therapeutic effect. By methodically adjusting these structural parameters rather than creating entirely new complex frameworks, the invention achieves potent 5-HT6 selectivity while managing structural complexity in a controlled manner.
Data Source
AI summary
Provided herein are novel aromatic heterocyclic compounds or a stereoisomer, a geometric isomer, a tautomer, an N-oxide, a hydrate, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug thereof, and their uses for treating Alzheimer's disease. Also provided herein are pharmaceutical compositions containing such compounds, and methods for using such compounds or pharmaceutical compositions thereof to treat Alzheimer's disease.